# SMIM32

## Overview
SMIM32, or small integral membrane protein 32, is a gene that encodes a transmembrane protein involved in various biological processes. The protein is characterized by its integration into cellular membranes, suggesting a role in cellular signaling or structural integrity. Research has highlighted its potential significance in oncology, particularly in pancreatic adenocarcinoma, where its expression levels are inversely correlated with disease progression and metastasis (Dong2021LiverMetastasisRelated). Additionally, SMIM32 is notably expressed in specific brain regions, such as the claustrum and thalamic reticular nucleus, indicating a possible role in neurological functions (Ibrahim2019Transcriptomic). Despite these associations, the precise biological functions and mechanisms of SMIM32 remain to be fully elucidated, warranting further investigation into its role in both cancer biology and neuroscience.

## Clinical Significance
SMIM32 has been identified as a protective gene in the context of pancreatic adenocarcinoma (PAAD). Its expression is inversely related to the risk of liver metastasis and overall survival in PAAD patients. Low expression of SMIM32 is associated with higher risk scores and poorer clinical outcomes, suggesting that alterations in its expression could contribute to disease progression (Dong2021LiverMetastasisRelated). Genetic alterations in SMIM32 have been linked to higher overall survival rates, indicating a potential protective role in PAAD (Dong2021LiverMetastasisRelated).

In the field of neuroscience, SMIM32 is highly expressed in the claustrum and thalamic reticular nucleus, with significant up-regulation observed in these regions. It is among the top-ranked genes in the claustrum, intersecting between adult and fetal data, which suggests its importance in this brain region (Ibrahim2019Transcriptomic). However, the specific clinical implications of SMIM32 in neurological conditions remain unclear, as the research primarily focuses on its expression patterns rather than direct links to diseases (Ibrahim2019Transcriptomic). Further studies are needed to elucidate the full clinical significance of SMIM32 in both cancer and neurological disorders.


## References


[1. (Ibrahim2019Transcriptomic) Christine Ibrahim, Bernard Le Foll, and Leon French. Transcriptomic characterization of the human insular cortex and claustrum. Frontiers in Neuroanatomy, November 2019. URL: http://dx.doi.org/10.3389/fnana.2019.00094, doi:10.3389/fnana.2019.00094. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnana.2019.00094)

[2. (Dong2021LiverMetastasisRelated) Yinlei Dong, Junjie Tian, Bingqian Yan, Kun Lv, Ji Li, and Deliang Fu. Liver-metastasis-related genes are potential biomarkers for predicting the clinical outcomes of patients with pancreatic adenocarcinoma. Pathology and Oncology Research, July 2021. URL: http://dx.doi.org/10.3389/pore.2021.1609822, doi:10.3389/pore.2021.1609822. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/pore.2021.1609822)